| Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib |
|
Park, Sejeong
(Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center)
Park, Soyoung (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center) Choi, Hana (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center) Park, Ji Young (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center) Lim, Hyo Seok (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center) Park, Myung Jae (Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center) Kim, Si-Young (Department of Hematology-Oncology, Kyung Hee University Medical Center) |
| 1 | Cersosimo RJ. Gefitinib: an adverse effects profile. Expert Opin Drug Saf 2006;5:469-479. DOI |
| 2 | Yan X, Li M, Jiang M, Zou LQ, Luo F, Jiang Y. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer 2009;115:5018-5025. DOI |
| 3 | Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-174. DOI |
| 4 | Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006;43:577-584. DOI |
| 5 |
Brooks MB. Erlotinib and gefitinib, epidermal growth factor receptor kinase inhibitors, may treat non-cancer-related tumor necrosis factor- |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
